Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous pulse methylprednisolone vs dexamethasone for idiopathic sudden sensorineural hearing loss
TCTR20211224004Phase 4Recruiting
- Sponsor
- Sirinkarn Sookdee
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone, dexamethasone in idiopathic sudden sensorineural hearing loss (ISSNHL), sponsored by Sirinkarn Sookdee. Started Nov 2021; status: recruiting.
02
Drugs
methylprednisolonedexamethasone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on TCTR20211224004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211224004.